ESS vs STRO
Essex Property Trust Inc (ESS) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Essex Property Trust Inc (ESS) is a reit - residential company listed on NYSE.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported ESS revenue for 2024-12-31 was $1.77B. Net income was $811.3M. Revenue was up 6.3% from 2023-12-31 to 2024-12-31. ESS currently screens at market cap $18.91B and trailing P/E 30.9.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
ESS currently screens at market cap $18.91B and trailing P/E 30.9. STRO currently screens at market cap $470.8M.
Not investment advice. Open the ESS and STRO stock pages for the full models.
Not investment advice.